Inventors:
Gilbert A. Block - Ardmore PA
Assignee:
Merck Co., Inc. - Rahway NJ
International Classification:
A61K 31445
US Classification:
514315, 514408, 514438, 514461
Abstract:
The present invention provides a method of treating a neurodegenerative disease, and in particular Alzheimers disease, Mild Cognitive Impairment or other objective memory impairment which comprises the co-administration of ARICEPT or other cholinesterase inhibitor or cholenergic angonist and an effective amount of a selective COX-2 inhibitor. Although a wide range of COX-2 inhibitors may be employed in combination with ARICEPT, there are preferred choices which are specifically set forth herein.